BioStratum
Durham · Founded 1994
About BioStratum
BioStratum is develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications. Its products include Pyridorin, a small molecule drug for the treatment of diabetic kidney disease; and pre-clinical compounds that treat diabetic complications and cancer. The company was founded in 1994 and is headquartered in Durham, North Carolina.
Company Facts
- Founded: 1994
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.1M
- Funding stage: Seed
- Last round: Seed (Aug 2011)
- Website: biostratum.com
- Phone: +1 919-572-6515
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/biostratum-3339887 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.